Angiogenesis in vestibular schwannomas: Expression of extracellular matrix factors MMP‐2, MMP‐9, and TIMP‐1
- 22 March 2010
- journal article
- research article
- Published by Wiley in The Laryngoscope
- Vol. 120 (4) , 657-662
- https://doi.org/10.1002/lary.20834
Abstract
Objectives/Hypothesis: Vascular endothelial growth factor (VEGF) and matrix metalloproteinases (MMPs) are potent mediators of tumor angiogenesis. It has been demonstrated that vestibular schwannoma VEGF expression correlates with tumor growth pattern, whereas knowledge on the expression of MMPs is lacking. This study targets the angiogenic process by investigation of tumor expression of MMP‐2, MMP‐9, and tissue inhibitors of metalloproteinase (TIMP)‐1. A possible correlation with gender, patient age, symptom duration, tumor size, and the absolute and relative growth rate is explored. Study Design: Prospective vestibular schwannoma tissue sampling for ELISA and immunohistochemical determination of MMP‐2, MMP‐9 and TIMP‐1. Methods: Thirty‐four patients with a sporadic, noncystic, vestibular schwannoma were selected prospectively. Repeated, preoperative magnetic resonance imaging determined the tumor growth pattern. Following translabyrinthine resection, an enzyme‐linked immunosorbent assay was used for determination of the MMP‐2, MMP‐9, and TIMP‐1 concentration in tumor sample homogenates. Immunohistochemical labeling was performed in 12 randomly selected tumors. Results: All tumor homogenates expressed measurable MMP‐9, MMP‐2, and TIMP‐1. Immunolabeling localized MMP‐9 expression to the tumor cells, whereas MMP‐2 and TIMP‐1 was found interstitially. A significant correlation existed between the concentration MMP‐9 and absolute tumor growth rate, whereas a weak correlation occurred for the relative growth rate. Conclusions: Vestibular schwannomas express MMP‐2, MMP‐9, and TIMP‐1 and the tumor concentration of MMP‐9 correlates with absolute tumor growth rate, but not with age, gender, symptom duration, or preoperative tumor size. No correlations existed between any clinical parameter and MMP‐2 or TIMP‐1 expression. We conclude that MMP‐9 appears to be involved in the growth of vestibular schwannomas. Laryngoscope, 2010Keywords
This publication has 21 references indexed in Scilit:
- Matrix metalloproteinase‐2 is involved in myelination of dorsal root ganglia neuronsGlia, 2008
- Biology and potential clinical implications of tissue inhibitor of metalloproteinases-1 in colorectal cancer treatmentScandinavian Journal of Gastroenterology, 2008
- Endothelial sprouting and angiogenesis: matrix metalloproteinases in the leadCardiovascular Research, 2007
- Expression of Vascular Endothelial Growth Factor and Basic Fibroblast Growth Factor in Sporadic Vestibular Schwannomas Correlates to Growth CharacteristicsOtology & Neurotology, 2007
- Cystic vestibular schwannomas: a possible role of matrix metalloproteinase–2 in cyst development and unfavorable surgical outcomeJournal of Neurosurgery, 2007
- VEGF and VEGF Receptor-1 Concentration in Vestibular Schwannoma Homogenates Correlates to Tumor Growth RateOtology & Neurotology, 2005
- Immunohistochemical Demonstration of Vascular Endothelial Growth Factor in Vestibular Schwannomas Correlates to Tumor Growth RateThe Laryngoscope, 2003
- Vascular endothelial growth factor expression correlates with matrix metalloproteinases MT1‐MMP, MMP‐2 and MMP‐9 in human glioblastomasInternational Journal of Cancer, 2003
- The biology of VEGF and its receptorsNature Medicine, 2003
- Proteases in invasion: matrix metalloproteinasesSeminars in Cancer Biology, 2001